Bing Wang

USPTO Granted Patents = 64 (Patent Applications = 19)

CIPO Patents = 10 (Patent Applications = 10)

EPO Patents = 15 (Patent Applications = 17)

Average Co-Inventor Count = 2.5

ph-index = 16

Forward Citations = 880(Granted Patents)

Inventors with similar research interests:

Location History:

Summerville, SC (US) (2006)
Cupertino, CA (US) (2003 - 2014)
Aliso Viejo, CA (US) (2010 - 2014)
Brookfield, CT (US) (2011 - 2016)
Lincolnshire, IL (US) (2019)
Pleasanton, CA (US) (2020)
Corona, CA (US) (2021)
San Jose, CA (US) (2005 - 2022)

Company Filing History:

13 out of 135

Biomarin Pharmaceutical Inc.

patents

9 out of 408

Cytec Technology Corporation

patents

7 out of 9

Galileo Pharmaceuticals, Inc.

patents

4. 7 out of 63

Medivation Technologies, Inc.

Edison Pharmaceuticals, Inc.

patents

7. 2 out of 2

Ampere Life Sciences, Inc.

patents

8. 2 out of 498

Brocade Communications Systems, Inc.

patents

9. 2 out of 2,075

Siemens Medical Solutions Usa, Inc.

Foundry Networks, Inc.

patents

12. 1 out of 271

Johnson & Johnson Consumer Companies, Inc.

patents

13. 1 out of 4,442

Eli Lilly and Company

patents

14. 1 out of 16

J&j Consumer Companies, Inc.

Monsanto Technology LLC

patents

17. 7 out of 832,680

Other

patents

Years Active: 2003-2022

Loading Chart...

64 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11384055 - Glycolate oxidase inhibitors for the treatment of disease (2022-07-12),

2. 11364241 - Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) (2022-06-21),

3. 11358932 - N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors (2022-06-14),

4. 11076990 - System and method for ophthalmic laser surgery employing eye tracking without eye docking (2021-08-03),

5. 10927092 - Glucosylceramide synthase inhibitors for the treatment of diseases (2021-02-23),

6. 10780088 - Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) (2020-09-22),

7. 10759769 - Glucosylceramide synthase inhibitors for the treatment of diseases (2020-09-01),

8. 10722398 - Eye docking for laser eye surgery (2020-07-28),

9. 10543209 - Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) (2020-01-28),

10. 10493078 - Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency (2019-12-03),

11. 10245596 - Electrostatic modification reagent and process for enhancing electrostatic separation in the beneficiation of ores (2019-04-02),

12. 10239832 - N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors (2019-03-26),

13. 10227323 - Glucosylceramide synthase inhibitors for the treatment of diseases (2019-03-12),

14. 10227312 - Glucosylceramide synthase inhibitors for the treatment of diseases (2019-03-12),

15. 10189837 - Crystalline (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one tosylate salt (2019-01-29),

Title: Bing Wang: Pioneering Inventor from San Jose

Introduction: Bing Wang is a distinguished inventor based in San Jose, California, known for his groundbreaking contributions to various technological fields.

Latest Patents: Bing Wang's recent patents include innovative solutions in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Bing Wang has established himself as a leading figure in the tech industry, holding multiple patents and receiving recognition for his inventive spirit.

Collaborations: Throughout his career, Bing Wang has collaborated with top research institutions, leading companies, and talented individuals, fostering a culture of innovation and knowledge sharing.

Conclusion: Bing Wang's passion for innovation, coupled with his dedication to pushing the boundaries of technology, continues to inspire the next generation of inventors and entrepreneurs worldwide.

This text is generated by artificial intelligence and may not be accurate.